Literature DB >> 18079186

Catheter angiography, MR angiography, and MR perfusion in posterior reversible encephalopathy syndrome.

W S Bartynski1, J F Boardman.   

Abstract

BACKGROUND AND
PURPOSE: The cause of posterior reversible encephalopathy syndrome (PRES) is unknown. Two primary hypotheses exist: 1) hypertension exceeding auto-regulatory limits leading to forced hyper-perfusion and 2) vasoconstriction and hypo-perfusion leading to ischemia with resultant edema. The purpose of this study was to evaluate the catheter angiography (CA), MR angiography (MRA), and MR perfusion (MRP) features in PRES in order to render further insight into its mechanism of origin.
MATERIALS AND METHODS: In 47 patients with PRES, 9 CAs and 43 MRAs were evaluated for evidence of vasculopathy (vasoconstriction and vasodilation), and 15 MRP studies were evaluated for altered relative cerebral blood volume (rCBV) in PRES lesions and regions. Visualization of vessels on MRA and toxicity blood pressures were compared with the extent of hemispheric vasogenic edema.
RESULTS: Vasculopathy was present in 8 of 9 patients on CA (direct correlation to MRA in 3/6 patients). At MRA, moderate to severe vessel irregularity consistent with vasoconstriction and vasodilation was present in 30 of 43 patients and vessel pruning or irregularity in 7 patients, with follow-up MRA demonstrating reversal of vasoconstriction or vasodilation in 9 of 11 patients. Vasogenic edema was less in patients with hypertension compared with patients who were normotensive. Preserved normal length of the posterior cerebral artery (PCA) was commonly seen in patients with severe hypertension despite diffuse or focal vasoconstriction or vasodilation. In these patients, lengthier visualization of the distal PCA correlated with a lower grade of hemispheric edema (P = .002). Cortical rCBV was significantly reduced in 51 of 59 PRES lesions and regions compared with a healthy reference cortex (average 61% of reference cortex) with mild decrease in the remainder.
CONCLUSION: Vasculopathy was a common finding on CA and MRA in our patients with PRES, and MRP demonstrated reduced cortical rCBV in PRES lesions. Vasogenic edema was reduced in patients with hypertension, and superior distal PCA visualization correlated with reduced hemispheric edema in patients with PRES and severe hypertension.

Entities:  

Mesh:

Year:  2007        PMID: 18079186      PMCID: PMC8118858          DOI: 10.3174/ajnr.A0839

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  33 in total

1.  Assessment of cerebral microcirculation in a patient with hypertensive encephalopathy using MR perfusion imaging.

Authors:  S T Engelter; J R Petrella; M J Alberts; J M Provenzale
Journal:  AJR Am J Roentgenol       Date:  1999-12       Impact factor: 3.959

2.  Quantitative assessment of diffusion abnormalities in posterior reversible encephalopathy syndrome.

Authors:  J M Provenzale; J R Petrella; L C Cruz; J C Wong; S Engelter; D P Barboriak
Journal:  AJNR Am J Neuroradiol       Date:  2001-09       Impact factor: 3.825

3.  Posterior reversible encephalopathy syndrome in infection, sepsis, and shock.

Authors:  W S Bartynski; J F Boardman; Z R Zeigler; R K Shadduck; J Lister
Journal:  AJNR Am J Neuroradiol       Date:  2006 Nov-Dec       Impact factor: 3.825

4.  Variable incidence of cyclosporine and FK-506 neurotoxicity in hematopoeitic malignancies and marrow conditions after allogeneic bone marrow transplantation.

Authors:  Walter S Bartynski; Zella R Zeigler; Richard K Shadduck; John Lister
Journal:  Neurocrit Care       Date:  2005       Impact factor: 3.210

5.  Hemodynamic and permeability changes in posterior reversible encephalopathy syndrome measured by dynamic susceptibility perfusion-weighted MR imaging.

Authors:  Lauren M Brubaker; J Keith Smith; Yueh Z Lee; Weili Lin; Mauricio Castillo
Journal:  AJNR Am J Neuroradiol       Date:  2005-04       Impact factor: 3.825

Review 6.  The microcirculation during endotoxemia.

Authors:  R S McCuskey; R Urbaschek; B Urbaschek
Journal:  Cardiovasc Res       Date:  1996-10       Impact factor: 10.787

7.  MR imaging, MR angiography, and MR spectroscopy of the brain in eclampsia.

Authors:  A R Sengar; R K Gupta; A K Dhanuka; R Roy; K Das
Journal:  AJNR Am J Neuroradiol       Date:  1997-09       Impact factor: 3.825

Review 8.  Pathogenesis of acute graft-versus-host disease: cytokines and cellular effectors.

Authors:  J L Ferrara
Journal:  J Hematother Stem Cell Res       Date:  2000-06

9.  Prolonged reversible vasospasm in cyclosporin A-induced encephalopathy.

Authors:  Jen-Tsun Lin; Shuu-Jiun Wang; Jong-Ling Fuh; Lian-Tsai Hsiao; Jiing-Feng Lirng; Po-Min Chen
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

10.  MR imaging of reversible cyclosporin A-induced neurotoxicity.

Authors:  C L Truwit; C P Denaro; J R Lake; T DeMarco
Journal:  AJNR Am J Neuroradiol       Date:  1991 Jul-Aug       Impact factor: 3.825

View more
  67 in total

1.  Multimodal imaging of reversible cerebral vasoconstriction syndrome: a series of 6 cases.

Authors:  C P Marder; M M Donohue; J R Weinstein; K R Fink
Journal:  AJNR Am J Neuroradiol       Date:  2012-03-15       Impact factor: 3.825

2.  Licorice-associated reversible cerebral vasoconstriction with PRES.

Authors:  N Chatterjee; K Domoto-Reilly; P E Fecci; L H Schwamm; A B Singhal
Journal:  Neurology       Date:  2010-11-23       Impact factor: 9.910

Review 3.  Late postpartum eclampsia complicated with posterior reversible encephalopathy syndrome: a case report and a literature review.

Authors:  Lihong Zhang; Yacong Wang; Liang Shi; Jianhui Cao; Zhenzhong Li; Yì-Xiáng J Wáng
Journal:  Quant Imaging Med Surg       Date:  2015-12

4.  Posterior reversible encephalopathy syndrome coexists with acute cerebral infarction: challenges of blood pressure management.

Authors:  Luji Liu; Lihong Zhang
Journal:  Quant Imaging Med Surg       Date:  2020-12

Review 5.  Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features.

Authors:  W S Bartynski
Journal:  AJNR Am J Neuroradiol       Date:  2008-03-20       Impact factor: 3.825

6.  PRES (posterior reversible encephalopathy syndrome), a rare complication of tacrolimus therapy.

Authors:  P Hodnett; J Coyle; K O'Regan; M M Maher; N Fanning
Journal:  Emerg Radiol       Date:  2008-12-19

7.  Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance?

Authors:  Christina Mueller-Mang; Thomas Mang; Agnes Pirker; Katharina Klein; Christine Prchla; Daniela Prayer
Journal:  Neuroradiology       Date:  2009-02-21       Impact factor: 2.804

8.  Posterior Reversible Encephalopathy Syndrome: The Spectrum of MR Imaging Patterns.

Authors:  O Kastrup; M Schlamann; C Moenninghoff; M Forsting; S Goericke
Journal:  Clin Neuroradiol       Date:  2014-02-20       Impact factor: 3.649

9.  Imaging pattern of intracranial hemorrhage in the setting of posterior reversible encephalopathy syndrome.

Authors:  Aseem Sharma; Ryan T Whitesell; Kelsey J Moran
Journal:  Neuroradiology       Date:  2009-12-03       Impact factor: 2.804

10.  Posterior reversible encephalopathy syndrome after intrathecal methotrexate infusion: a case report and literature update.

Authors:  Efterpi Pavlidou; Evangelos Pavlou; Athanasia Anastasiou; Zoi Pana; Vasiliki Tsotoulidou; Maria Kinali; Emmanuel Hatzipantelis
Journal:  Quant Imaging Med Surg       Date:  2016-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.